2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Clinical Chemotherapy
Clinical chemotherapy stands as a cornerstone in cancer research, representing a multifaceted approach to battling malignancies. This therapeutic strategy employs drugs that target rapidly dividing cancer cells, impeding their growth or inducing cell death. Over decades of research, chemotherapy has evolved significantly, with tailored regimens designed to combat specific cancer types. From traditional cytotoxic agents to novel targeted therapies and immunotherapies, the arsenal against cancer continues to expand. However, chemotherapy's efficacy often comes with notable side effects, including nausea, hair loss, and compromised immune function. Research endeavors strive to refine treatment protocols, minimizing adverse effects while maximizing therapeutic benefits. Through rigorous clinical trials and innovative drug development, the field of clinical chemotherapy remains at the forefront of the ongoing fight against cancer, offering hope and progress to patients worldwide.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China